3D Systems Corporation

3D Systems Corporation (DDD) Market Cap

3D Systems Corporation has a market capitalization of .

No quote data available.

CEO: Jeffrey Alan Graves

Sector: Technology

Industry: Computer Hardware

IPO Date: 1988-03-10

Website: https://www.3dsystems.com

3D Systems Corporation (DDD) - Company Information

Market Cap: -|Sector: Technology

Company Profile

3D Systems Corporation, operating globally across the Americas, Europe, the Middle East, Africa, and Asia Pacific regions, specializes in delivering advanced 3D printing and digital manufacturing solutions. Its product portfolio includes a diverse array of 3D printers utilizing technologies like stereolithography, selective laser sintering, direct metal printing, multi-jet printing, color jet printing, extrusion, and SLA-based bioprinting. These systems are designed to convert digital input, sourced from 3D design software, CAD programs, or other digital modeling tools, into tangible physical components. Beyond hardware, the company formulates, produces, and distributes an extensive selection of print materials, encompassing plastics, nylon, metals, composites, elastomers, waxes, polymeric dental compounds, and biocompatible substances. Under its Geomagic brand, 3D Systems supplies a suite of digital design tools, which includes specialized software, scanners, and haptic devices. These offerings facilitate a broad spectrum of applications such as product design, simulation, mold and die creation, 3D scan-to-print workflows, reverse engineering, production machining, metrology, inspection, and comprehensive manufacturing process management. Proprietary software solutions are also a core offering. This includes 3D Sprint and 3DXpert, platforms engineered to streamline CAD data preparation and optimization, as well as overseeing additive manufacturing processes through features like automated support generation, build platform oversight, print simulation, and queue management. Additionally, Bioprint Pro serves as a dedicated software solution empowering researchers to design and execute reproducible bioprinting experiments. The corporation further extends its value proposition through a range of services, including maintenance, technical training, contract manufacturing, software support, and precision healthcare solutions. Its clientele spans a wide spectrum, from small and medium-sized enterprises to large corporations, across numerous sectors such as medical, dental, automotive, aerospace, defense, technology, durable goods, government, jewelry, electronics, education, consumer products, energy, and biotechnology. Sales and distribution are managed via a direct sales force, strategic channel partners, and authorized distributors. Established in 1986, 3D Systems Corporation maintains its corporate headquarters in Rock Hill, South Carolina.

Analyst Sentiment

58%
Buy

From 4 Active Polls

1Y Forecast: $5.00

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$5

Median

$5

High Bound

$5

Average

$5

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$5.00
▲ +89.39% Upside
Low Target
$5.00
89% Risk
Median Target
$5.00
89% Mid
High Target
$5.00
89% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 3D SYSTEMS CORP (DDD) — Investment Overview

🧩 Business Model Overview

3D Systems participates across the additive manufacturing (AM) value chain: (1) selling AM hardware (printers and production systems), (2) enabling production workflows through software, and (3) generating follow-on revenue from consumables/materials, service, and post-sale support. The model tends to be “installed-base driven”: once customers qualify a specific platform, material set, and process workflow, the unit economics improve through recurring service/support contracts and repeat purchases of proprietary or tightly integrated consumables. This customer qualification and process validation creates meaningful stickiness, particularly in regulated or production environments.

💰 Revenue Streams & Monetisation Model

Monetisation typically mixes transactional and recurring components:

  • Equipment and system sales (transactional): Printer/system shipments and related hardware typically carry higher variability and are sensitive to industrial capex cycles.
  • Materials/consumables (repeat purchase): Powders/resins/other input materials and consumables can provide steady demand once customers scale part production.
  • Service, maintenance, and support (recurring/contractual): Installed-base maintenance and technical support tend to recur and stabilize revenue visibility.
  • Software/workflow and integration (recurring potential): Software that supports scanning, design-to-part workflows, production monitoring, and manufacturing management can monetize over time, depending on bundling and customer rollout cadence.

Primary margin drivers generally include (1) attach rates of consumables and service to hardware, (2) mix shift toward software/workflows and higher-value production solutions, and (3) manufacturing efficiencies in producing systems and materials. Over time, the revenue durability thesis rests on increasing recurring revenue as customers move from experimentation to certified, repeatable production.

🧠 Competitive Advantages & Market Positioning

Moat: switching costs from qualified workflows and production know-how; plus intangible assets in materials/process validation and customer-specific application support.

Competitors can enter the category with new hardware, but taking share away from an established AM customer often requires passing practical barriers: requalification of processes, validation of material performance, integration into existing production workflows, and assurance of repeatability and uptime. This “process lock-in” creates switching friction, especially where downstream requirements exist (aerospace/defense certification needs, medical device production constraints, and production-rate expectations).

  • Stratasys: Strong positioning in polymer AM and broader platform adoption. Compared with Stratasys, 3D Systems tends to emphasize production-oriented solutions across metals/polymers and an end-to-end workflow approach.
  • Materialise: More software/workflow-centric, with less emphasis on manufacturing hardware scale. Compared with Materialise, 3D Systems’ monetisation is more tied to hardware plus consumables/service attach.
  • Desktop Metal / GE Additive ecosystem: Positioned around industrial AM throughput and certain metal process routes. Compared with these rivals, 3D Systems competes through platform breadth, application expertise, and materials/process integration that supports customer qualification cycles.

Hard to displace: The barrier is not only the machine; it is the qualified combination of machine + materials + software workflow + service responsiveness. That integrated system reduces the probability of a rapid “rip-and-replace” transition for production users.

🚀 Multi-Year Growth Drivers

  • Industrial adoption of AM in production: Continued expansion from prototyping into functionally critical end-use parts and low-to-medium volume manufacturing where design freedom and part consolidation improve economics.
  • Certification and qualification maturation: As more applications gain regulatory or customer acceptance, AM becomes a repeatable production method rather than a research tool.
  • Supply chain resilience and inventory optimization: Nearer-term production capabilities and reduced dependence on long lead times can support adoption, particularly for spare parts and tooling.
  • Workflow digitization: Software-enabled process planning, scanning, inspection, and manufacturing management drive adoption by reducing operational friction and improving throughput.
  • Materials innovation and application engineering: Better material performance and application-specific support can expand TAM within aerospace/defense, industrial components, and healthcare manufacturing workflows.

Over a 5–10 year horizon, the TAM expansion case depends on sustained customer conversion from experimentation to qualified production runs, which increases recurring consumables and service revenue exposure.

⚠ Risk Factors to Monitor

  • Technology/process disruption: Shifts among AM process technologies (e.g., metal process route changes) can render platforms less competitive, requiring investment to maintain parity on speed, quality, and cost.
  • Customer qualification timelines: AM adoption often involves extended validation cycles; delays can postpone scaling and weigh on conversion from pilots to production.
  • Capex cyclicality and demand concentration: Equipment purchases can track industrial spending and can be impacted by budget tightening and inventory corrections.
  • Competitive pricing and platform overlap: Hardware competition can pressure system margins, emphasizing the need for continued attach of higher-margin consumables, service, and software.
  • Capital intensity and execution risk: Sustaining R&D, scaling production of systems/materials, and maintaining service networks require consistent investment.
  • Regulatory and application-specific standards: In healthcare and aerospace-like applications, quality systems and documentation requirements elevate compliance risk and constrain product transitions.

📊 Valuation & Market View

The market often values AM platforms through a blend of industrial-tech expectations rather than pure software multiples:

  • EV/EBITDA and EV/Sales sensitivity: Hardware-heavy revenue mixes can lead to valuation focus on operating leverage when volume ramps.
  • Recurring revenue mix as a driver: Higher proportions of service/support and consumables typically improve perceived earnings durability.
  • Gross margin structure: Mix toward consumables, service, and software can influence both margin trajectory and valuation support.
  • Unit economics and utilization: For production users, throughput and uptime matter; improvements can drive demand and retention.

Key valuation “needle movers” tend to be (1) evidence of installed-base growth and attach, (2) progress in scaling production applications, and (3) margin resilience amid competitive pricing.

🔍 Investment Takeaway

3D Systems’ long-term investment case rests on converting customers from pilot use to qualified production, where switching costs are elevated by process validation, workflow integration, and consumables/service dependency. The durable core is the installed-base dynamic—hardware as the entry point, followed by repeatable materials and support—positioned to benefit from the structural shift toward AM in industrial and regulated applications. The principal underwriting risk is sustaining technology competitiveness and scaling adoption through customer qualification cycles without allowing hardware margin erosion to overwhelm the recurring revenue build.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"DDD reported Q1’26 revenue of $95.5M and net loss of $4.4M (EPS -$0.03). QoQ, revenue fell from $106.3M (Q4’25) to $95.5M (-10.2%), and net loss narrowed from -$19.5M to -$4.4M (improving ~77%). YoY, revenue was roughly flat vs Q1’25 ($94.5M; +1.0%), but profitability improved meaningfully: net loss improved from -$37.0M in Q1’25 to -$4.4M in Q1’26 (a ~88% improvement). Margins improved across the latest year: gross margin rose to 35.9% (from 34.6% in Q1’25), while operating margin and net margin remained negative (-6.9% operating; -4.6% net), indicating costs are still not fully under control. Cash flow quality is mixed: operating cash flow was -$7.2M and free cash flow was -$9.3M in Q1’26. The company remains liquid (cash & short-term investments $85.1M), but cash decreased QoQ. Balance sheet leverage appears manageable with net debt of -$27.7M (net cash), though total equity is small and diluted profitability limits near-term per-share value creation. Shareholder returns: price is up 16.1% over 1 year; with no dividends and no buybacks recorded in this dataset, total shareholder return is primarily price-driven. Analysts show a static consensus price target ($5) versus current price ($2.24)."

Revenue Growth

Neutral

Revenue was nearly flat YoY (+1.0% vs Q1’25) but declined QoQ (-10.2% vs Q4’25), suggesting softer near-term demand.

Profitability

Caution

Net loss improved sharply YoY (from -$37.0M to -$4.4M; ~-88%), and QoQ (from -$19.5M to -$4.4M). However, margins are still negative (operating margin -6.9%, net margin -4.6%).

Cash Flow Quality

Caution

Operating cash flow was -$7.2M and free cash flow -$9.3M in Q1’26. Despite recent loss improvement, the quarter still consumed cash and reduced cash QoQ.

Leverage & Balance Sheet

Neutral

Liquidity remains solid (cash & equivalents $85.1M) and net debt is negative (net cash of -$27.7M). Equity is thin, but balance sheet resilience is better than earlier periods with high net debt.

Shareholder Returns

Neutral

1-year price gain of +16.1% supports capital appreciation. No dividends are present and buybacks are not reflected here, limiting return drivers beyond price momentum.

Analyst Sentiment & Valuation

Fair

Consensus target is $5 versus current ~$2.24 (implies upside), but targets are not moving in the provided data; valuation upside exists while earnings power remains weak.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

DDD delivered a positive Q1 with $95.5M revenue (+11% YoY) and 36.1% non-GAAP gross margin (+6pp YoY), driven by improved manufacturing absorption, consumables mix, and printer margin gains alongside cost actions. Adjusted EBITDA turned positive at $2.1M, helped by sharply lower non-GAAP operating expenses ($36.6M, -35% YoY) and favorable expense timing. While EPS remained a small non-GAAP loss (-$0.01), it improved meaningfully from -$0.21. Growth was broad: Med Tech and Dental posted double-digit YoY increases, and Aerospace & Defense continued >20% YoY expansion. The “so what” is operational execution: portfolio refresh is translating into printer, parts, and materials momentum (notably NextDent 300 with ROE tripling capacity). The main offset is external volatility—Middle East-linked logistics disruptions and modest FX/tariff pressure—plus near-term seasonality pressure in Q2 (guided revenue $93M-$95M; adjusted EBITDA loss $2M-$4M). Management remains cautious but targets full-year adjusted EBITDA breakeven or better.

AI IconGrowth Catalysts

  • Double-digit year-over-year growth in Med Tech printer and medical parts manufacturing, driven by titanium spinal implants plus titanium and cobalt chrome joint implants
  • Dental momentum acceleration: double-digit year-over-year growth in aligner demand and Vertex prosthetic repair materials after U.S. regulatory approval and ongoing ramp
  • NextDent 300 denture platform traction: ROE Dental Laboratory became first major U.S. lab to deploy extensive fleet; ROE tripled high-precision multi-material monolithic denture capacity
  • Aerospace & Defense metal printer-driven growth: >20% year-over-year segment growth and demand linked to space, naval, and aero propulsion applications

Business Development

  • ROE Dental Laboratory (premier full-service digital dental lab): deployed extensive fleet of NextDent 300 Jetted Denture printing systems across multiple sites; expanded purchases to effectively triple manufacturing capacity
  • Large global healthcare customer: increased requirements for print know-how transfer for a transition to high-volume parts manufacturing (expected to complete in 2027)
  • U.S. denture market launch customer actions: ROE expanded purchases after fall 2025 U.S. launch
  • Aerospace & Defense manufacturing expansion program tied to customer demand for high-end materials (titanium, zirconium, nickel-based alloys, and copper-nickel alloys for Navy propulsion)

AI IconFinancial Highlights

  • Revenue: $95.5M, +11% year-over-year
  • Non-GAAP gross margin: 36.1%, up 6 percentage points year-over-year (benefits from manufacturing absorption, favorable consumables mix, improved printer margins, and cost initiatives)
  • Non-GAAP operating expenses: $36.6M, down 35% year-over-year (down $20.1M adjusted for software divestitures); operating expenses declined 11% sequentially
  • Adjusted EBITDA: +$2.1M, improved by $26M year-over-year (or +$28.2M adjusted for divestitures)
  • EPS: non-GAAP loss per share of $0.01, improving from a loss of $0.21 prior year period
  • Offsetting headwinds: supply chain disruptions tied to Middle East conflict; isolated customer disruption resolved by quarter end; modest FX and tariff impacts; net effect characterized as largely offsetting with minimal adjusted EBITDA impact

AI IconCapital Funding

  • Cash: $86.5M total cash at quarter end ($85.1M cash and cash equivalents; $1.4M restricted cash)
  • Debt maturities: $3.9M due in Q4 2026; remaining $92M maturing in 2030
  • No buyback amounts disclosed in transcript

AI IconStrategy & Ops

  • Cost reduction: more than $55M annualized cost savings delivered through end of Q1 2026; defined cost reduction/efficiency programs expected to complete by end of Q2 (6-quarter effort)
  • R&D pacing change: after launching new jewelry printer MJP 300 Plus, NextDent 300 printers/materials, and DMP metal upgrades, company expects to transition to a more balanced R&D level with targeted portfolio enhancements
  • Littleton, Colorado expansion: adding 80,000 square feet of manufacturing space; grand opening on track for late summer (end of July / beginning of August)
  • Facility re-purposing: adjacent building to pivot from primarily healthcare parts manufacturing toward industrial part manufacturing, expected to be primarily aerospace parts; plan to add printers over H2 2026

AI IconMarket Outlook

  • Q2 2026 guidance: revenue $93M to $95M; adjusted EBITDA loss of $2M to $4M
  • Full-year framing: management expects breakeven adjusted EBITDA or better for the full year (implies recovery from Q2 seasonality)

AI IconRisks & Headwinds

  • Middle East conflict impacting supply chain/logistics; specific mention that it has disrupted logistics for printers, parts, and materials to customers (including some in the Middle East)
  • Customer-specific disruption in Med Tech/parts (temporary internal operations issue) partially offset Q1 growth; resolved by quarter end with demand recovery expected in Q2
  • Tariff and FX impacts described as modest to bottom line
  • Seasonality risk: Q2 described as a seasonal dip for healthcare due to procedure timing (dental and orthopedics) and summer travel effects

Q&A: Analyst Interest

  • Topic: Q2 revenue guide drivers and whether anything was pulled forward: Management said the guide aligns with “measured” caution; they denied pull-forwards. Overachievement versus guidance was attributed to legitimate uptick in demand in certain sectors in Q1. Seasonality remains a key factor, especially in dental and orthopedics.
  • Topic: Path to adjusted EBITDA breakeven for the year despite Q2 loss: Management cited favorable expense timing in Q1 and noted operating expense stability through the year with normal seasonality. They emphasized consumables/product mix—heavy printer sales and increased metal printer mix—supporting margin improvements each quarter.
  • Topic: Healthcare growth composition (Med Tech/personalized health care vs Dental) and metal parts expansion focus: Management said both Med Tech and Dental contributed to double-digit growth, with Med Tech rebound expected after a customer disruption. Metal parts expansion adds 80,000 sq ft adjacent to existing Littleton facility for aerospace high-end materials.

Sentiment: MIXED

Note: This summary was synthesized by AI from the DDD Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — 3D Systems Corporation (DDD) Financial Profile